BARDA
E656712
BARDA is a U.S. government agency within the Department of Health and Human Services that funds and coordinates advanced research, development, and procurement of medical countermeasures against public health emergencies, including pandemics, bioterrorism, and emerging infectious diseases.
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
U.S. government agency
ⓘ
public health preparedness organization ⓘ |
| abbreviation | BARDA NERFINISHED ⓘ |
| activity |
advanced procurement of medical countermeasures for national stockpiles
ⓘ
funding advanced development of diagnostics ⓘ funding advanced development of medical devices ⓘ funding advanced development of therapeutics ⓘ funding advanced development of vaccines ⓘ |
| collaboratesWith |
academic institutions
ⓘ
biotechnology companies ⓘ international partners ⓘ other U.S. federal agencies ⓘ pharmaceutical companies ⓘ |
| country | United States of America ⓘ |
| establishedFor | improving U.S. preparedness for public health emergencies ⓘ |
| focusArea |
antimicrobial resistance
ⓘ
bioterrorism ⓘ chemical threats ⓘ emerging infectious diseases ⓘ pandemic influenza ⓘ radiological and nuclear threats ⓘ |
| fullName | Biomedical Advanced Research and Development Authority NERFINISHED ⓘ |
| fundingMechanism |
advanced research and development contracts
ⓘ
project grants and cooperative agreements ⓘ public-private partnerships ⓘ |
| headquartersLocation | Washington, D.C. ⓘ |
| jurisdiction | Federal government of the United States NERFINISHED ⓘ |
| legalAuthority | Pandemic and All-Hazards Preparedness Act NERFINISHED ⓘ |
| oversees | advanced development portfolios for multiple threat areas ⓘ |
| parentAgency |
Office of the Assistant Secretary for Preparedness and Response
NERFINISHED
ⓘ
U.S. Department of Health and Human Services NERFINISHED ⓘ |
| primaryMission |
advanced research and development of medical countermeasures
ⓘ
procurement of medical countermeasures ⓘ support for public health emergency preparedness and response ⓘ |
| responsibility |
bridging the gap between early-stage research and product licensure
ⓘ
supporting late-stage clinical development of countermeasures ⓘ supporting manufacturing scale-up of countermeasures ⓘ supporting regulatory approval of medical countermeasures ⓘ |
| roleInBiodefense |
supports medical countermeasures against biological threats
ⓘ
supports medical countermeasures against bioterrorism agents ⓘ |
| roleInPandemics |
supports development and procurement of antiviral drugs
ⓘ
supports development and procurement of diagnostic tests ⓘ supports development and procurement of pandemic vaccines ⓘ |
| sector |
biomedical research and development
ⓘ
public health ⓘ |
| worksOn |
COVID-19 medical countermeasures
ⓘ
Ebola medical countermeasures ⓘ Zika medical countermeasures ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.